SLC39A4

Across TCGA pan-cancer cohorts, SLC39A4 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated SLC39A4 data layer compared with 24 for mass-spec protein and 1 for mass-spec protein.

The strongest signal is observed in small cell lung cancer (SCLC), where higher SLC39A4 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated SLC39A4 expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

SCLC, LUAD, and STAD are the cancer types where SLC39A4 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SCLC	OS	Median	All	0.055	0.708	<.001	36	view →
LUAD	OS	Median	All	0.153	0.835	<.001	20	view →
STAD	OS	Median	III,IV	1.000	0.366	.046	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

SLC39A4–SCLC (OS)

Open the SCLC breakdown →